|
1
|
Lee SM, Lee YJ, Kim YC, Kim JS, Kang DG
and Lee HS: Vascular protective role of vitexicarpin isolated from
Vitex rotundifolia in human umbilical vein endothelial cells.
Inflammation. 35:584–593. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Madonna R, Massaro M, Pandolfi A, Consoli
A and De Caterina R: The prominent role of p38 mitogen-activated
protein kinase in insulin-mediated enhancement of VCAM-1 expression
in endothelial cells. Int J Immunopathol Pharmacol. 20:539–555.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Z, Niu Q, Peng X, Li M, Liu Y, Liu J,
Wen S and Wei Y: Mitofusin 2 ameliorates aortic remodeling by
suppressing ras/raf/ERK pathway and regulating mitochondrial
function in vascular smooth muscle cells. Int J Cardiol.
178:165–167. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park B, Yim JH, Lee HK, Kim BO and Pyo S:
Ramalin inhibits VCAM-1 expression and adhesion of monocyte to
vascular smooth muscle cells through MAPK and PADI4-dependent NF-κB
and AP-1 pathways. Biosci Biotechnol Biochem. 79:539–552. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martin-Blanco E: p38 MAPK signalling
cascades: Ancient roles and new functions. Bioessays. 22:637–645.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chahine MN, Blackwood DP, Dibrov E,
Richard MN and Pierce GN: Oxidized LDL affects smooth muscle cell
growth through MAPK-mediated actions on nuclear protein import. J
Mol Cell Cardiol. 46:431–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang GF, Shi CG, Sun MZ, Wang L, Wu SX,
Wang HF, Xu ZQ and Chen DM: Tetramethylpyrazine attenuates
atherosclerosis development and protects endothelial cells from
ox-LDL. Cardiovasc Drugs Ther. 27:199–210. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fisk M, Gajendragadkar PR, Mäki-Petäjä KM,
Wilkinson IB and Cheriyan J: Therapeutic potential of p38 MAP
kinase inhibition in the management of cardiovascular disease. Am J
Cardiovasc Drugs. 14:155–165. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Glaros EN, Kim WS and Garner B:
Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is
associated with ERK inhibition. Clin Sci (Lond). 118:727–736. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dhanasekaran DN and Reddy EP: JNK
signaling in apoptosis. Oncogene. 27:6245–6251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yarza R, Vela S, Solas M and Ramirez MJ:
c-Jun N-terminal Kinase (JNK) signaling as a therapeutic target for
Alzheimer's disease. Front Pharmacol. 6:3212016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei L, Deng W, Cheng Z, Guo H, Wang S,
Zhang X, He Y and Tang Q: Effects of hesperetin on platelet-derived
growth factor-BB-induced pulmonary artery smooth muscle cell
proliferation. Mol Med Rep. 13:955–960. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cui Y, Sun YW, Lin HS, Su WM, Fang Y, Zhao
Y, Wei XQ, Qin YH, Kohama K and Gao Y: Platelet-derived growth
factor-BB induces matrix metalloproteinase-2 expression and rat
vascular smooth muscle cell migration via ROCK and ERK/p38 MAPK
pathways. Mol Cell Biochem. 393:255–263. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim MH, Kang HM, Kim CE, Han S and Kim SW:
Ramipril inhibits high glucose-stimulated up-regulation of adhesion
molecules via the ERK1/2 MAPK signaling pathway in human umbilical
vein endothelial cells. Cell Mol Biol Lett. 20:937–947. 2015.
View Article : Google Scholar : PubMed/NCBI
|
